Catalyst Pharmaceuticals ...

NASDAQ: CPRX · Real-Time Price · USD
24.87
-0.09 (-0.36%)
At close: Jun 02, 2025, 3:59 PM
24.82
-0.20%
After-hours: Jun 02, 2025, 07:55 PM EDT

Catalyst Pharmaceuticals Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
License And Other Revenue Revenue 2.41M 1.7M 265K 138M
License And Other Revenue Revenue Growth +41.42% +542.26% -99.81% n/a
Product Revenue Net Revenue 489.33M 396.5M 213.94M 2.84M
Product Revenue Net Revenue Growth +23.41% +85.34% +7443.65% n/a

Revenue by Geography

Period Ending Dec 31, 2020
Canada Revenue 33K
Canada Revenue Growth n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017 Dec 31, 2016 Sep 30, 2016 Jun 30, 2016 Mar 31, 2016 Dec 31, 2015 Sep 30, 2015 Jun 30, 2015 Mar 31, 2015
Selling, General, and Administrative Revenue 46.91M 44.19M 45.88M 40.73M 46.94M 42.04M 33.56M 28.4M 29.72M 14.67M 13.65M 12.92M 16.43M 13.23M 12.15M 11.53M 12.72M 13.35M 9.98M 10.83M 10.06M 11.41M 8.07M 8.99M 8.42M 6.93M 3.64M 2.63M 2.67M 2.11M 1.6M 1.73M 1.87M 1.49M 1.42M 2.31M 2.69M 2.36M 1.97M 2.32M 1.94M
Selling, General, and Administrative Revenue Growth +6.15% -3.68% +12.64% -13.23% +11.66% +25.26% +18.19% -4.45% +102.60% +7.47% +5.66% -21.38% +24.22% +8.84% +5.39% -9.31% -4.77% +33.72% -7.83% +7.65% -11.80% +41.42% -10.24% +6.79% +21.51% +90.06% +38.51% -1.62% +26.92% +31.55% -7.39% -7.31% +24.93% +5.18% -38.41% -14.33% +14.03% +19.51% -14.87% +19.43% n/a
Research and Development Revenue 3.89M 3.8M 3.28M 2.98M 2.58M 1.97M 83.66M 3.95M 3.56M 4.09M 8.31M 3.98M 3.4M 4.99M 4.49M 4.45M 3.01M 4.18M 3.75M 4.35M 4.22M 6.31M 4.6M 4.63M 3.31M 8.42M 4.54M 3.7M 3.26M 3.4M 2.7M 2.45M 2.81M 2.82M 2.49M 2.51M 3.55M 3.83M 3.04M 2.58M 2.35M
Research and Development Revenue Growth +2.34% +15.65% +10.02% +15.65% +30.88% -97.64% +2015.88% +11.01% -12.97% -50.75% +108.64% +17.04% -31.83% +11.25% +0.83% +47.99% -27.98% +11.36% -13.80% +3.00% -33.06% +37.23% -0.70% +39.95% -60.70% +85.46% +22.50% +13.68% -4.28% +25.87% +10.33% -12.87% -0.24% +13.10% -0.59% -29.25% -7.44% +25.93% +18.05% +9.70% n/a
Sales and Marketing Revenue 29.9M 30.67M 29.11M 26.25M 25.32M 28.93M 21.68M 18.31M 17.76M 7.83M 7.58M 7.27M 6.79M 7.97M 6.52M 5.98M 5.68M 6.56M 5.58M 5.62M 5.8M n/a 4.67M 4.88M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales and Marketing Revenue Growth -2.51% +5.38% +10.89% +3.66% -12.48% +33.44% +18.40% +3.08% +126.96% +3.20% +4.35% +7.04% -14.85% +22.28% +9.03% +5.37% -13.51% +17.64% -0.77% -3.14% n/a -100.00% -4.31% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a